全文获取类型
收费全文 | 754篇 |
免费 | 33篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 22篇 |
妇产科学 | 24篇 |
基础医学 | 86篇 |
口腔科学 | 7篇 |
临床医学 | 71篇 |
内科学 | 161篇 |
皮肤病学 | 10篇 |
神经病学 | 37篇 |
特种医学 | 9篇 |
外科学 | 162篇 |
综合类 | 10篇 |
预防医学 | 64篇 |
眼科学 | 16篇 |
药学 | 46篇 |
中国医学 | 3篇 |
肿瘤学 | 51篇 |
出版年
2024年 | 4篇 |
2023年 | 17篇 |
2022年 | 40篇 |
2021年 | 50篇 |
2020年 | 31篇 |
2019年 | 31篇 |
2018年 | 37篇 |
2017年 | 14篇 |
2016年 | 20篇 |
2015年 | 32篇 |
2014年 | 40篇 |
2013年 | 29篇 |
2012年 | 61篇 |
2011年 | 75篇 |
2010年 | 35篇 |
2009年 | 38篇 |
2008年 | 61篇 |
2007年 | 46篇 |
2006年 | 42篇 |
2005年 | 32篇 |
2004年 | 19篇 |
2003年 | 13篇 |
2002年 | 7篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1998年 | 3篇 |
1995年 | 1篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1980年 | 2篇 |
1974年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有790条查询结果,搜索用时 9 毫秒
91.
Sameen Ahmed Ayesha Vajeeha Muhammad Idrees Abrar Hussain Rakhtasha Munir Gulshan Zaidi Khadija Zahid Rizwan Ahmed Zareen Fatima Shazia Rafique Niaz M. Achakzai 《Medicine》2023,102(2)
High-risk-human papillomavirus (HR-HPV)-induced cervical cancer is the second most common cause of death among females worldwide. HPV16 is the most prevalent HR-HPV infection worldwide. This study found the genotypic distribution of HR-HPV in the local population and investigated the sequence variations among the E6 and E7 oncogenes of the local HPV16 genotype to the E6 and E7 oncogenes of the foreign HPV16 genotypes and constructed a phylogenetic relationship based on nucleotide sequence comparison among the variants identified in our study along with previously reported isolates that were obtained from different regions of the world. The samples were collected from patients with cervical cancer. Genomic DNA was extracted, and HR-HPV genotypes were determined using real-time PCR. The HPV16 E6 and E7 genes were amplified and sequenced. A HPV16 phylogenetic tree was constructed using the maximum likelihood method with MEGA 7. HPV16 was the most prevalent human papillomavirus (HPV) type identified in the present study. HPV16 isolates belonged to the A1 sublineage of the European branch. Twenty-one nucleotide sequences were included in this analysis. The first, second, and third codon positions are also included. The final dataset included 776 positions. 相似文献
92.
Faris MoezAlIslam E. Vitiello Michael V. Abdelrahim Dana N. Cheikh Ismail Leila Jahrami Haitham A. Khaleel Sharfa Khan Maryam S. Shakir Ayman Z. Yusuf Ayesha M. Masaad Alyaa A. Bahammam Ahmed S. 《Sleep & breathing》2022,26(3):1365-1376
Sleep and Breathing - This study investigated the relationships between eating habits and sleep quality among university students. In a cross-sectional study, university students completed a... 相似文献
93.
94.
95.
96.
Shah N Sattar A Benanti M Hollander S Cheuck L 《The Journal of the American Osteopathic Association》2006,106(1):23-27
OBJECTIVES: To review the use of magnetic resonance spectroscopy (MRS) as a clinical tool in the identification of cerebral neoplasia type and grade, as well as neoplasia in the prostate, colon, breast, cervix, pancreas, and esophagus. Also, to review how clinicians are using MRS for surgical planning and longitudinal evaluation of tumors after treatment. DATA SOURCES: Studies and clinical case reports published within the previous 10 years, targeting publications in radiology and oncology journals within the previous 3 years. Sources identified via MEDLINE and PubMed databases. STUDY SELECTION: Studies that contrasted MRS with conventional diagnostic and prognostic methods were considered to yield the most relevant data for this review. Studies discussing cancer staging and grading were also examined to help determine clinical significance of MRS. DATA SYNTHESES: A review of the literature reveals that, although MRS has mainly been used in diagnostics and tumor evaluation for brain cancer, it is becoming an increasingly important adjunct to conventional diagnostic and monitoring procedures for cancer of the prostate, colon, breast, cervix, pancreas, and esophagus. CONCLUSIONS: The clinical usefulness of MRS has yet to be fully substantiated. As MRS availability and access increases, appropriate evaluations of its strengths and weaknesses will be made. The authors conclude that research to date and primary observation indicate that MRS is a promising clinical tool for oncologic management of patients. 相似文献
97.
98.
99.
Dhir V Fort M Mahmood A Higbee R Warren W Narayanan P Wittman V 《Journal of immunotoxicology》2012,9(1):34-42
Human peripheral blood mononuclear cells (PBMC) are routinely used in vitro to detect cytokine secretion as part of preclinical screens to delineate agonistic and antagonistic action of therapeutic monoclonal antibodies (mAbs). Preclinical value of standard human PBMC assays to detect cytokine release syndrome (CRS) has been questioned, as they did not predict the "cytokine storm" that occurred when healthy human volunteers were given a CD28-specific super-agonist mAb, TGN1412. In this article, we describe a three-dimensional biomimetic vascular test-bed that can be used as a more physiologically relevant assay for testing therapeutic Abs. For developing such a system, we used TGN1412 as a model mAb. We tested soluble TGN1412 on various combinations of human blood components in a module containing endothelial cells grown on a collagen scaffold and measured cytokine release using multiplex array. Our system, consisting of whole leukocytes, endothelial cells, and 100% autologous platelet-poor plasma (PPP) consistently produced proinflammatory cytokines in response to soluble TGN1412. In addition, other mAb therapeutics known to induce CRS or first infusion reactions, such as OKT3, Campath-1H, or Herceptin, generated cytokine profiles in our model system consistent with their in vivo responses. As a negative control we tested the non-CRS mAbs Avastin and Remicade and found little difference between these mAbs and the placebo control. Our data indicate that this novel assay may have preclinical value for predicting the potential of CRS for mAb therapeutics. 相似文献
100.
Douglas J. Minnich Patrick Yu Ayesha S. Bryant Doraid Jarrar Robert J. Cerfolio 《European journal of cardio-thoracic surgery》2011,40(4):931-937
Objective: To assess our results of a prospective algorithm applied to patients with thoracic esophageal perforation. Methods: A retrospective review of a prospective algorithm. Patients with esophageal perforation underwent an esophagram. If there was a contained esophageal perforation they were admitted, kept nothing by mouth, and restudied in 3–5 days. If the leak was not contained, they underwent operative repair. Results: From 1/1998 to 6/2009 there were 81 patients. The gastrograffin swallow showed 56 patients had contained perforations and 25 did not. Twenty-two of the 25 patients with noncontained perforation underwent immediate operative repair (one patient refused surgery, two were not stable enough for the operating room); their morbidity was 68% and there were six (24%) operative mortalities. Median hospital length of stay (LOS) was 11 days (range, 2–120). Of the 56 patients with contained perforations, 26 were managed successfully without surgery. However, 30 of the patients initially treated nonoperatively eventually required operations due to new pleural effusion, mediastinal abscess, or conversion to noncontained perforation. Their morbidity was 41% and there were three operative mortalities (5%). On univariate analysis, these patients were more likely to have undergone previous esophageal procedures (surgical or dilation) (p = 0.03), had new or increased pleural effusion (p = 0.04), and had greater than 24 h between diagnosis and treatment (p = 0.02). Only greater than 24 h between diagnosis and treatment remained a significant predictor on multivariate analysis. Their median hospital LOS was 21 days (range, 7–77). Conclusion: Contained thoracic esophageal perforations can usually be safely managed nonoperatively without significant morbidity or mortality. However, careful in-hospital monitoring is needed if surgery is not chosen. 相似文献